Camptothecin: a key building block in the design of anti-tumor agents.
作者信息
Liu Bowen, Yao Lei
机构信息
School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Yantai, China.
Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System, Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.
出版信息
Future Med Chem. 2025 Feb;17(4):381-384. doi: 10.1080/17568919.2025.2458455. Epub 2025 Jan 25.
Abstract
摘要
相似文献
1
Camptothecin: a key building block in the design of anti-tumor agents.喜树碱：抗肿瘤药物设计中的关键组成部分。
Future Med Chem. 2025 Feb;17(4):381-384. doi: 10.1080/17568919.2025.2458455. Epub 2025 Jan 25.
2
Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.在小鼠肿瘤中，将拓扑异构酶I抑制剂添加到三联疗法[顺二氯二氨铂（II）/热/辐射]中。
J Cancer Res Clin Oncol. 1993;119(11):645-51. doi: 10.1007/BF01215982.
3
Enhanced delivery of camptothecin to colorectal carcinoma using a tumor-penetrating peptide targeting p32.使用靶向p32的肿瘤穿透肽增强喜树碱向结直肠癌的递送。
Acta Biomater. 2025 Jun 15;200:629-640. doi: 10.1016/j.actbio.2025.05.036. Epub 2025 May 14.
4
Functional identification of 10-hydroxygeraniol oxidoreductases related to camptothecin biosynthesis in Ophiorrhiza pumila.与蛇根草中喜树碱生物合成相关的10-羟基香叶醇氧化还原酶的功能鉴定
Int J Biol Macromol. 2025 Jul;318(Pt 3):145253. doi: 10.1016/j.ijbiomac.2025.145253. Epub 2025 Jun 13.
5
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC).TROP-2 定向抗体药物偶联物（ADC）：在晚期非小细胞肺癌（NSCLC）中智能药物递送的革命。
Cancer Treat Rev. 2023 Jul;118:102572. doi: 10.1016/j.ctrv.2023.102572. Epub 2023 May 19.
6
Deuterium substitution at the intolerable site as a strategy to mitigate the toxicity of camptothecin derivatives.在难以耐受的位点进行氘代取代作为减轻喜树碱衍生物毒性的一种策略。
Eur J Med Chem. 2025 Oct 15;296:117877. doi: 10.1016/j.ejmech.2025.117877. Epub 2025 Jun 17.
7
Anaesthesia for mandibular premolars with symptomatic irreversible pulpitis - which nerve block is best?下颌前磨牙伴症状性不可逆性牙髓炎的麻醉——哪种神经阻滞最佳？
Evid Based Dent. 2025 Apr 21. doi: 10.1038/s41432-025-01142-7.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗：一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.伊立替康、奥沙利铂和雷替曲塞用于治疗晚期结直肠癌：系统评价与经济学评估
Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. doi: 10.3310/hta12150.
10
UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis.UGT1A1*6基因多态性与伊立替康所致中性粒细胞减少症的相关性：一项系统评价和荟萃分析
Cancer Chemother Pharmacol. 2017 Jul;80(1):135-149. doi: 10.1007/s00280-017-3344-3. Epub 2017 Jun 5.
引用本文的文献
1
Potential Active Compounds of and Their Anticancer Effects: A Comprehensive Review.及其潜在活性化合物与抗癌作用：综述
Food Sci Nutr. 2025 Aug 1;13(8):e70741. doi: 10.1002/fsn3.70741. eCollection 2025 Aug.
本文引用的文献
1
Design, synthesis and cytotoxic activity of sulfonylated derivatives of camptothecin.喜树碱磺酰化衍生物的设计、合成及细胞毒性活性
Nat Prod Res. 2024 Aug 18:1-10. doi: 10.1080/14786419.2024.2392739.
2
Discovery of novel HER2 targeting peptide-camptothecin conjugates with effective suppression for selective cancer treatment.发现新型 HER2 靶向肽-喜树碱缀合物，有效抑制选择性癌症治疗。
Bioorg Chem. 2024 Jun;147:107371. doi: 10.1016/j.bioorg.2024.107371. Epub 2024 Apr 15.
3
20-esterification of 5-spiro CPT and their anticancer activity in vitro.5-螺环喜树碱的20-酯化反应及其体外抗癌活性
Nat Prod Res. 2024 Apr 8:1-9. doi: 10.1080/14786419.2024.2337115.
4
Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements.释放喜树碱的潜力：探索结构修饰与治疗学发展的创新策略。
J Med Chem. 2024 Mar 14;67(5):3244-3273. doi: 10.1021/acs.jmedchem.3c02115. Epub 2024 Feb 29.
5
Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates.ZD06519 的设计与评估：一种新型喜树碱类药物载体用于抗体偶联药物。
Mol Cancer Ther. 2024 May 2;23(5):606-618. doi: 10.1158/1535-7163.MCT-23-0822.
6
Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma.喜树碱结构简化得到新型咪唑并[2,1-b]喹唑啉衍生物，作为一种人拓扑异构酶 I 抑制剂，对骨肉瘤细胞和结肠腺癌细胞具有疗效。
Eur J Med Chem. 2024 Feb 5;265:116049. doi: 10.1016/j.ejmech.2023.116049. Epub 2023 Dec 16.
7
Synthesis and biological evaluation of novel quaternary ammonium antibody drug conjugates based on camptothecin derivatives.基于喜树碱衍生物的新型季铵抗体药物偶联物的合成与生物学评价。
PLoS One. 2023 Dec 19;18(12):e0292871. doi: 10.1371/journal.pone.0292871. eCollection 2023.
8
Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors.设计、合成新型融合肽及其 CPT 缀合物，并评估其在 HER2 阳性肿瘤上诱导有效抗肿瘤反应的活性。
Eur J Med Chem. 2024 Jan 15;264:116032. doi: 10.1016/j.ejmech.2023.116032. Epub 2023 Dec 7.
9
Stimulus-Responsive Nano-Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery.刺激响应型纳米前药策略用于癌症治疗：以喜树碱递药为重点。
Small Methods. 2024 Aug;8(8):e2301271. doi: 10.1002/smtd.202301271. Epub 2023 Dec 12.
10
New benzothienopyran and benzothienopyranopyrimidine derivatives as topoisomerase I inhibitors: Design, synthesis, anticancer screening, apoptosis induction and molecular modeling studies.新型苯并噻喃并苯并嘧啶衍生物作为拓扑异构酶 I 抑制剂的设计、合成、抗癌筛选、凋亡诱导及分子模拟研究。
Bioorg Chem. 2023 Aug;137:106638. doi: 10.1016/j.bioorg.2023.106638. Epub 2023 May 27.
Zotero 插件